These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12677245)

  • 21. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in medicinal chemistry.
    Cavalla D; Gilmore J
    Drug News Perspect; 1998 Dec; 11(10):658-63. PubMed ID: 15616636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines.
    Alavijeh MS; Palmer AM
    IDrugs; 2004 Aug; 7(8):755-63. PubMed ID: 15334309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of natural products in drug discovery and development in the new millennium.
    Harvey A
    IDrugs; 2010 Feb; 13(2):70-2. PubMed ID: 20127553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New horizons in drug metabolism, pharmacokinetics and drug discovery.
    Palmer AM
    Drug News Perspect; 2003; 16(1):57-62. PubMed ID: 12682673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Diversity-Based Approach for the Discovery of Stereoselective Polymerization Catalysts: Identification of a Catalyst for the Synthesis of Syndiotactic Polypropylene This work was supported by the Cornell Center for Materials Research (CCMR), a Materials Research Science and Engineering Center of the National Science Foundation (DMR-9632275), and the Exxon Chemical Corporation. G.W.C. gratefully acknowledges an NSF Career Award (CHE-9875261), a Camille and Henry Dreyfus New Faculty Award, a Research Corporation Research Innovation Award, an Alfred P. Sloan Research Fellowship, an Arnold and Mabel Beckman Foundation Young Investigator Award, a Camille Dreyfus Teacher-Scholar Award, a 3M Untenured Faculty Grant, an IBM Partnership Award, and a Union Carbide Innovation Recognition Award.
    Tian J; Coates GW
    Angew Chem Int Ed Engl; 2000 Oct; 39(20):3626-3629. PubMed ID: 11091419
    [No Abstract]   [Full Text] [Related]  

  • 31. International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.
    Bodovitz S
    IDrugs; 2010 Jan; 13(1):23-5. PubMed ID: 20024843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NCI-EORTC Symposia on New Drugs in Cancer Therapy: A Brief History.
    Krul MR
    Oncologist; 1998; 3(4):269-270. PubMed ID: 10388114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metal based drugs: from serendipity to design.
    Fricker SP
    Dalton Trans; 2007 Nov; (43):4903-17. PubMed ID: 17992275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Products in Drug Discovery and Development. 27-28 June 2005, London, UK.
    Harvey A
    IDrugs; 2005 Sep; 8(9):719-21. PubMed ID: 16118691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics.
    Posner BA
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):487-94. PubMed ID: 16022185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking-related lung disease: prospects for new drug therapy.
    Hansel TT
    Drug News Perspect; 2001 Apr; 14(3):175-80. PubMed ID: 12819824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunities and barriers in the age of team science: strategies for success.
    Sellers TA; Caporaso N; Lapidus S; Petersen GM; Trent J
    Cancer Causes Control; 2006 Apr; 17(3):229-37. PubMed ID: 16489530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cells as screening tools in drug discovery.
    McNeish JD
    Curr Opin Pharmacol; 2007 Oct; 7(5):515-20. PubMed ID: 17681491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.